Your cart is empty
Start Shopping$80.00
This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.
Molecular Formula | C14H22N4O9 |
CAS Number | 307297-39-8 |
Molar Mass | 390.35 g/mol |
Amino Acid Sequence | Ala-Glu-Asp-Gly |
PubChem CID | 219042 |
Primary Research Area |
Aging Longevity Telomeres Telomerase Activation Pineal Gland Function Melatonin Regulation Circadian Rhythms Antioxidant Immune System Modulation Cancer Prevention Neuroprotection Retinal Diseases Cellular Regeneration Stress Adaptation |
Purity | >99% |
Research Summary | Description |
---|---|
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity |
Summary: This recent in vitro study explored the mechanism by which Epitalon influences telomere length in various human cell lines, including normal epithelial cells, fibroblasts, and breast cancer cell lines. The research demonstrated that Epitalon could induce telomere length extension in normal healthy mammalian cells. This effect was achieved through the upregulation of hTERT (human telomerase reverse transcriptase) mRNA expression and a subsequent increase in telomerase enzyme activity. Interestingly, in cancer cell lines, significant telomere length extension also occurred, primarily through the activation of ALT (Alternative Lengthening of Telomeres) pathways, with only a minor increase in ALT activity observed in normal cells. Citation: [PDF] Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity - ResearchGate. (n.d.). Retrieved July 31, 2025, from https://www.researchgate.net/publication/393742676_Epitalon_increases_telomere_length_in_human_cell_lines_through_telomerase_upregulation_or_ALT_activity |
Epithalamin and Epitalon in ocular disorders: an update |
Summary: This review specifically focuses on the therapeutic potential of Epithalamin and its synthetic analog Epitalon in various ocular disorders. It summarizes studies suggesting that these peptides can exert beneficial effects on the retina and other eye tissues, potentially due to their antioxidant properties, ability to improve microcirculation, and influence on cellular metabolism and proliferation. The review discusses their application in conditions like retinitis pigmentosa and age-related macular degeneration (AMD), which are often associated with oxidative stress and cellular dysfunction. Citation: Ostrovskaya, M. O., Zabezhinski, M. A., Popovich, I. G., & Khavinson, V. K. (2012). Epithalamin and Epitalon in ocular disorders: an update. Journal of Clinical and Experimental Ophthalmology, S4(006). |
Effect of Epithalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice |
Summary: This preclinical study investigated the long-term effects of Epithalon on various biomarkers of aging, lifespan, and spontaneous tumor incidence in female SHR mice. The mice were treated with Epithalon at a very low dose (0.1 micrograms, 5 times a week) or saline. While Epithalon did not significantly influence food consumption, body weight, or mean life span, it did slow down the age-related switching-off of estrous function, decreased the frequency of chromosome aberrations in bone marrow cells, and significantly increased the maximum life span (by 12.3%) and the life span of the last 10% of survivors (by 13.3%). Notably, it also inhibited the development of leukemia six-fold, although it did not influence total spontaneous tumor incidence. Citation: Anisimov, V. N., Semenchenko, A. V., & Popovich, I. G. (2002). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Mechanisms of Ageing and Development, 123(10), 1279–1290. |
Epithalon influences spontaneous tumor formation and lifespan in C3H/He mice |
Summary: This study investigated the effects of long-term (6.5 months) low-dose Epithalon administration (0.1 micrograms, 5 times a week) on spontaneous tumor incidence and lifespan in female C3H/He mice. The results indicated that while Epithalon did not significantly prolong the mean lifespan, it significantly reduced the total spontaneous tumor incidence (by 38.3%) and the incidence of mammary adenocarcinomas (by 2.5-fold). Furthermore, the treatment slowed the development of spontaneous tumor metastases, with no metastases found in the experimental mice compared to the control group where metastases from reproductive organ tumors were observed. Citation: Anisimov, V. N., Popovich, I. G., & Zabezhinski, M. A. (2001). Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer, 91(3), 398–402. |
Effect of Epitalon on age-related changes of the neuroendocrine-immune system and tumor development |
Summary: This review discusses how Epitalon, by influencing the pineal gland, can modulate the neuroendocrine-immune system and thereby affect age-related diseases, including cancer. It highlights that Epitalon normalizes melatonin production in aged individuals, which in turn can restore the circadian rhythm of neuroendocrine and immune parameters. The paper suggests that these effects contribute to its anti-tumor activity and overall geroprotective effects by optimizing communication between these crucial regulatory systems that often decline with age. Citation: Khavinson, V. K., & Anisimov, V. N. (2006). Effect of Epitalon on age-related changes of the neuroendocrine-immune system and tumor development. Annals of the New York Academy of Sciences, 1085(1), 223–236. |
Summary: This recent in vitro study explored the mechanism by which Epitalon influences telomere length in various human cell lines, including normal epithelial cells, fibroblasts, and breast cancer cell lines. The research demonstrated that Epitalon could induce telomere length extension in normal healthy mammalian cells. This effect was achieved through the upregulation of hTERT (human telomerase reverse transcriptase) mRNA expression and a subsequent increase in telomerase enzyme activity. Interestingly, in cancer cell lines, significant telomere length extension also occurred, primarily through the activation of ALT (Alternative Lengthening of Telomeres) pathways, with only a minor increase in ALT activity observed in normal cells.
Citation:
[PDF] Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity - ResearchGate. (n.d.). Retrieved July 31, 2025, from https://www.researchgate.net/publication/393742676_Epitalon_increases_telomere_length_in_human_cell_lines_through_telomerase_upregulation_or_ALT_activity
Summary: This review specifically focuses on the therapeutic potential of Epithalamin and its synthetic analog Epitalon in various ocular disorders. It summarizes studies suggesting that these peptides can exert beneficial effects on the retina and other eye tissues, potentially due to their antioxidant properties, ability to improve microcirculation, and influence on cellular metabolism and proliferation. The review discusses their application in conditions like retinitis pigmentosa and age-related macular degeneration (AMD), which are often associated with oxidative stress and cellular dysfunction.
Citation:
Ostrovskaya, M. O., Zabezhinski, M. A., Popovich, I. G., & Khavinson, V. K. (2012). Epithalamin and Epitalon in ocular disorders: an update. Journal of Clinical and Experimental Ophthalmology, S4(006).
Summary: This preclinical study investigated the long-term effects of Epithalon on various biomarkers of aging, lifespan, and spontaneous tumor incidence in female SHR mice. The mice were treated with Epithalon at a very low dose (0.1 micrograms, 5 times a week) or saline. While Epithalon did not significantly influence food consumption, body weight, or mean life span, it did slow down the age-related switching-off of estrous function, decreased the frequency of chromosome aberrations in bone marrow cells, and significantly increased the maximum life span (by 12.3%) and the life span of the last 10% of survivors (by 13.3%). Notably, it also inhibited the development of leukemia six-fold, although it did not influence total spontaneous tumor incidence.
Citation:
Anisimov, V. N., Semenchenko, A. V., & Popovich, I. G. (2002). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Mechanisms of Ageing and Development, 123(10), 1279–1290.
Summary: This study investigated the effects of long-term (6.5 months) low-dose Epithalon administration (0.1 micrograms, 5 times a week) on spontaneous tumor incidence and lifespan in female C3H/He mice. The results indicated that while Epithalon did not significantly prolong the mean lifespan, it significantly reduced the total spontaneous tumor incidence (by 38.3%) and the incidence of mammary adenocarcinomas (by 2.5-fold). Furthermore, the treatment slowed the development of spontaneous tumor metastases, with no metastases found in the experimental mice compared to the control group where metastases from reproductive organ tumors were observed.
Citation:
Anisimov, V. N., Popovich, I. G., & Zabezhinski, M. A. (2001). Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer, 91(3), 398–402.
Summary: This review discusses how Epitalon, by influencing the pineal gland, can modulate the neuroendocrine-immune system and thereby affect age-related diseases, including cancer. It highlights that Epitalon normalizes melatonin production in aged individuals, which in turn can restore the circadian rhythm of neuroendocrine and immune parameters. The paper suggests that these effects contribute to its anti-tumor activity and overall geroprotective effects by optimizing communication between these crucial regulatory systems that often decline with age.
Citation:
Khavinson, V. K., & Anisimov, V. N. (2006). Effect of Epitalon on age-related changes of the neuroendocrine-immune system and tumor development. Annals of the New York Academy of Sciences, 1085(1), 223–236.
Your cart is empty
Start Shopping